Recall of due to reduced efficacy

Vaccines List of authorised vaccines List of vaccines no longer authorised Austrian Vaccination Plan Vaccination Recommendations Reactions and side effects after vaccinations Vaccine safety: informati

Impfstoffliste_BMG_alteProdukte.xlsx In Österreich verwendete Impfstoffe im Zeitraum von 1950 bis Juni 2025 Impfstoffliste seit 1950 Stand: Juni 2025 Seite 1 von 7 Produktname (alphabetisch geordnet)

Referenced at:

• Vaccines

Microsoft Word - Impfstoffliste alphabetisch 2021-02-08_barrierefrei.docx Produktname Firma Indikation Zielgruppe Bemerkungen Adjuvans Thiomersal In Österreich zugelassene Impfstoffe Stand: Juni 2025

Referenced at:

• Vaccines

Quality Management The quality system of the Austrian federal Office for Safety in Health Care is operated by the Austrian Medicines and Medical Devices Agency and implements the requirements of ISO 9

Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der ECDC (European Centre for Disease Prevention and Control) mitgeteilt, dass bestätigte autochthone Chikungunya-Fälle in den Départements Var (La Crau) und Hérault (Prades le Lez) verzeichnet wurden.

Referenced at:

• Update: Chikungunya - France

Scope of Assessment EUROPEAN NETWORK OF OFFICIAL MEDICINES CONTROL LABORATORIES FINAL SCOPE OF ASSESSMENT OF MJA 09/24 Page 1/6 FORM/155 – Rev. 06 [19/10/2020] General Information Laboratory audited B

Referenced at:

• Quality Management

Certificate of free sale For the export of CE-marked medical devices and in vitro diagnostic medical devices to countries outside the European Union, a certificate of free sale (CFS) may be required.

ESMP for marketing authorisation holder New To better monitor and, if necessary, counteract supply shortages of medicinal products at EU level, the European Shortages Monitoring Platform ( ESMP ) was

To better monitor and, if necessary, counteract supply shortages of medicinal products at EU level, the European Shortages Monitoring Platform (ESMP) was established by the EMA in accordance with the Regulation (EU) 2022/123. The full version of the platform was launched in January 2025.